Lung Cancer Panel 2 EGFR ALK1 ROS1
Introduction
The Lung Cancer Panel 2 EGFR ALK1 ROS1 test is a crucial diagnostic tool designed to identify specific genetic alterations associated with lung cancer. In recent years, advancements in genetic testing have transformed the landscape of oncology, allowing for more personalized treatment approaches. This panel focuses on three key mutations: EGFR, ALK1, and ROS1, which are vital in guiding targeted therapies for lung cancer patients.
What the Test Measures
This test detects mutations in the EGFR, ALK1, and ROS1 genes within tumor tissue samples. These mutations can significantly influence the course of treatment and the overall prognosis for patients diagnosed with non-small cell lung cancer (NSCLC).
Who Should Consider This Test
The Lung Cancer Panel 2 EGFR ALK1 ROS1 test is recommended for individuals diagnosed with lung cancer, especially those exhibiting:
- Persistent cough or changes in coughing patterns
- Unexplained weight loss
- Shortness of breath
- Chest pain
- History of smoking or exposure to secondhand smoke
Additionally, patients with a family history of lung cancer or those with risk factors such as occupational exposure to carcinogens may also benefit from this test.
Benefits of Taking the Test
- Identifies specific genetic mutations that can inform treatment options.
- Helps in selecting targeted therapies that may improve treatment outcomes.
- Facilitates early detection of lung cancer, potentially leading to better survival rates.
- Provides valuable information for clinical decision-making and personalized care.
Understanding Your Results
Results from the Lung Cancer Panel 2 EGFR ALK1 ROS1 test will indicate the presence or absence of genetic mutations. A positive result may suggest the suitability of targeted therapies, while a negative result may lead to alternative treatment strategies. It is essential to discuss your results with your healthcare provider to understand their implications fully.
Test Pricing
| Test Name | Discount Price (NGN) | Regular Price (NGN) |
|---|---|---|
| Lung Cancer Panel 2 EGFR ALK1 ROS1 | 450000 | 600000 |
Book the Test
The Lung Cancer Panel 2 EGFR ALK1 ROS1 test requires a doctor’s prescription, except for patients undergoing surgery, those who are pregnant, or planning to travel abroad. The turnaround time for results is typically 5-7 days. To book your test or for more information, please call or WhatsApp us at +2348077798758.
